View daily, weekly or monthly format back to when Sage Therapeutics, Inc. Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Discover historical prices for SAGE stock on Yahoo Finance. Performance and returns of any investment portfolio can neither be predicted nor guaranteed.
Get the latest Sage Therapeutics, Inc SAGE detailed stock quotes, stock data, Real-Time ECN. Sage ERP X3 is the most powerful and flexible business management solution by Sage, for mid-sized and larger companies looking to grow a competitive business with limited IT resources. Discover historical prices for SAGE stock on Yahoo Finance. Please consider your specific investment requirements, risk tolerance, goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs. SAGE Therapeutics stock forecast & analyst price target predictions based on 13 analysts offering 12-months price targets for SAGE in the last 3 months. View Sage Therapeutics, Inc SAGE investment & stock information. What are analysts forecasts for Sage Therapeutics stock The 42 analysts offering price forecasts for Sage Therapeutics have a median target of 75.26, with a high estimate of 135.00 and a low. Past performance is not indicative of future returns. It accepts no liability for any damages or losses, however, caused in connection with the use of, or on the reliance of its advisory or related services. The Sage Group plc (SGE. Finzoom Investment Advisors Private Limited makes no warranties or representations, express or implied, on products and services offered through the platform. (SAGE) delivered earnings and revenue surprises of 1.39 and 14.62, respectively, for the quarter ended June 2022.
0 kommentar(er)
